Who
Joseph Patrick Cooper
Director
Company insider
Files Form 4 as: Director, Quoin Pharmaceuticals; EVP,Corp & Product Development, Medicis Pharmaceutical; Director, Bioenvision.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 3 Jan 2007
- Last trade
- 4 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,141 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,760 at $0.00 | filing |
| 9 Dec 2024filed 10 Dec 2024 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,714 at $0.00 | filing |
| 26 Oct 2023filed 30 Oct 2023 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,652 at $0.00 | filing |
| 4 Apr 2010filed 6 Apr 2010 | Medicis Pharmaceutical | SEC FORM 4 Code F | $29K1,140 at $25.02 | filing |
| 7 Mar 2010filed 9 Mar 2010 | Medicis Pharmaceutical | SEC FORM 4 Code F | $29K1,270 at $23.09 | filing |
| 1 Mar 2010filed 3 Mar 2010 | Medicis Pharmaceutical | SEC FORM 4 Code A | —48,479 at $0.00 | filing |
| 27 Feb 2010filed 2 Mar 2010 | Medicis Pharmaceutical | SEC FORM 4 Code F | $71K3,177 at $22.50 | filing |
| 7 Feb 2010filed 9 Feb 2010 | Medicis Pharmaceutical | SEC FORM 4 Code F | $14K640 at $22.27 | filing |
| 21 Jul 2009filed 23 Jul 2009 | Medicis Pharmaceutical | SEC FORM 4 Code F | $8,892566 at $15.71 | filing |
| 4 Apr 2009filed 7 Apr 2009 | Medicis Pharmaceutical | SEC FORM 4 Code F | $14K1,126 at $12.24 | filing |
| 7 Mar 2009filed 10 Mar 2009 | Medicis Pharmaceutical | SEC FORM 4 Code F | $7,387720 at $10.26 | filing |
| 27 Feb 2009filed 3 Mar 2009 | Medicis Pharmaceutical | SEC FORM 4 Code A | —97,518 at $0.00 | filing |
| 7 Feb 2009filed 10 Feb 2009 | Medicis Pharmaceutical | SEC FORM 4 Code F | $5,072423 at $11.99 | filing |
| 21 Jul 2008filed 23 Jul 2008 | Medicis Pharmaceutical | SEC FORM 4 Code F | $7,091368 at $19.27 | filing |
| 4 Apr 2008filed 8 Apr 2008 | Medicis Pharmaceutical | SEC FORM 4 Code A | —34,965 at $0.00 | filing |
| 7 Mar 2007filed 9 Mar 2007 | Medicis Pharmaceutical | SEC FORM 4 Code A | —19,490 at $0.00 | filing |
| 3 Jan 2007filed 5 Jan 2007 | Bioenvisionoption or derivative | SEC FORM 4 Code A | —6,250 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.